Rappta Therapeutics names new CEO
16 September 2021 -

Rappta Therapeutics, a private biotech company with operations in Finland, UK and US, announced on Wednesday that it has named Sunjeet Sawhney as its chief executive officer effective immediately.

Sawhney has more than 20 years of experience in the industry. He has served as the Global Head of the Oncology Franchise for Ipsen and headed businesses in biotech and major pharmaceutical companies.

Sawhney has an MSc in Immunology from the University of London and will be based in London.